Mednow Investor Relations Site
  • Home
  • News
  • Media
  • The Team
  • Stock Info
  • Investor Info
    • Financials
    • Governance Docs
    • Research Reports
    • Investor Presentation
  • Investor Contact
Select Page

News

Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth & 4800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO

Jun 15, 2022 | Press Release

Mednow to Host Quarterly Conference Call on Wednesday June 15, 2022, at 8:30am EST on its Third-Quarter 2022 Financial Results

Jun 8, 2022 | Press Release

Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors

May 9, 2022 | Press Release

Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175%

Apr 26, 2022 | Press Release

Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More

Apr 18, 2022 | Press Release

Mednow Closes Previously Announced Acquisition of Pharmacy in Toronto

Apr 1, 2022 | Press Release

Mednow to Attend DC Finance’s Montreal Conference on April 5th, 2022

Mar 30, 2022 | Press Release

Mednow to Attend Lytham Partners Spring 2022 Investor Conference

Mar 28, 2022 | Press Release

Mednow Achieves Record Q2 2022 Financial Results with 230% Q/Q Revenue Growth and 1,400% Y/Y Revenue Growth

Mar 23, 2022 | Press Release

Mednow to Attend 8th Annual AlphaNorth Capital Conference

Mar 22, 2022 | Press Release

« Older Entries

Quick Links

Executive Management

Investor FAQs

Sedar Filings

Investor Contact

Benjamin Ferdinand
ir@mednow.ca
+1 855 686 6300

Investor Email Alerts

Unsubscribe

© Mednow All Rights Reserved 2021

Privacy Policy
Mednow is now trading as MNOW in TSXV